Skip to main content
Log in

Glycine-to-arginine substitution at codon 145 of HBsAg in two infants Born to hepatitis B e antigen-positive carrier

  • Liver: Cirrhosis, Fibrosis, Portal Hypertension, And Transplantation
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Two daughters born to an HBeAg-positive carrier became hepatitis B virus carriers despite immunoprophylaxis with hepatitis B immune globulin or hepatitis B vaccine. The elder daughter received hepatitis B immune globulin alone and the younger daughter received both hepatitis B immune globulin and hepatitis B vaccine. They acquired anti-HBs passively immediately after birth, and the younger daughter did not respond to active immunization. The nucleotide sequence of the S gene of hepatitis B virus DNA from the four carriers in the family was determined. A 531-bp fragment within the S gene, which includes a region encoding both the commona and type-specificd/y orr/w determinants, was amplified by polymerase chain reaction and sequenced. Antigenic subtypes of HBV were identified asadr in the father andadw in both the mother and two daughters. Amino acid residues 122–160 of HBsAg were identical between the daughters and their mother except for a glycine-to-arginine substitution at codon 145. A possibility that this escape mutant had selective advantage over wild-type hepatitis B virus under immune pressure is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC: Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325–329, 1990

    PubMed  Google Scholar 

  2. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S: Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 32:264–268, 1992

    PubMed  Google Scholar 

  3. Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ: Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol 13:S105-S107, 1991

    PubMed  Google Scholar 

  4. Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M, Sakai Y, Okochi K, Nakajima E: Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 184:1152–1157, 1992

    PubMed  Google Scholar 

  5. Naoumov NV, Schneider R, Grotzinger T, Jung MC, Miska S, Pape GR, Will H: Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 102:538–543, 1993

    Google Scholar 

  6. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M: Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 324:1699–1704, 1991

    PubMed  Google Scholar 

  7. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K: The complete nucleotide sequences of the cloned hepatitis B virus DNA: subtype adr and adw. Nucleic Acids Res 11:1747–1757, 1983

    PubMed  Google Scholar 

  8. Okamoto H, Imai M, Shimozaki M, Hoshi Y, Iizuka H, Gotanda T, Tsuda F, Miyakawa Y, Mayumi M: Nucleotide sequence of a cloned hepatitis B virus genome, subtypeayr: comparison with genomes of the other three subtypes. J Gen Virol 67:2305–2314, 1986

    PubMed  Google Scholar 

  9. Galibert F, Mandart E, Fitoussi F, Tiollais P, Chanay P: Nucleotide sequence of the hepatitis B virus genome (subtype ayw) inE. coli. Nature 281:646–650, 1979

    PubMed  Google Scholar 

  10. Sanger F, Nicklen S, Coulson R: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467, 1977

    PubMed  Google Scholar 

  11. Niu MT, Targonski PV, Stoll BJ, Albert GP, Margolis HS: Prevention of perinatal transmission of the hepatitis B virus, Outcome of infants in a community prevention program. AJDC 146:793–796, 1992

    PubMed  Google Scholar 

  12. Beasley RP, Hwang LY, Lee GCY, Lan CC, Roan CH, Huang FY, Chen CL: Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2:1099–1102, 1983

    PubMed  Google Scholar 

  13. Hwang LY, Lee CY, Beasley RP: Five-year follow up of HBV vaccination with plasma-derived vaccine in neonates: evaluation of immunogenecity and efficacy against perinatal transmission.In Viral Hepatitis and Liver Disease. FB Hollinger, SM Lemon, HS Margolis (eds). Baltimore, Williams & Wilkins, 1990, pp 759–761.

    Google Scholar 

  14. Shimizu H, Mitsuda T, Ookawa N, Hujita S, Ibe M, Yolota S: Is the infant with intra-uterine HBV infection tolerant to HB vaccination? Clin Virol 18:66–70, 1990

    Google Scholar 

  15. McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI, Ostberg L: Genetic alternation in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 15:757–766, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hino, K., Okuda, M., Hashimoto, O. et al. Glycine-to-arginine substitution at codon 145 of HBsAg in two infants Born to hepatitis B e antigen-positive carrier. Digest Dis Sci 40, 566–570 (1995). https://doi.org/10.1007/BF02064370

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02064370

Key Words

Navigation